Saltar para:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Início > Publicações > Visualização > Mephedrone, the New Designer Drug of Abuse: Pharmacokinetics, Pharmacodynamics and Clinical and Forensic Issues

Publicações

Mephedrone, the New Designer Drug of Abuse: Pharmacokinetics, Pharmacodynamics and Clinical and Forensic Issues

Título
Mephedrone, the New Designer Drug of Abuse: Pharmacokinetics, Pharmacodynamics and Clinical and Forensic Issues
Tipo
Artigo em Revista Científica Internacional
Ano
2012
Autores
Ribeiro, E
(Autor)
Outra
A pessoa não pertence à instituição. A pessoa não pertence à instituição. A pessoa não pertence à instituição. Sem AUTHENTICUS Sem ORCID
Revista
Vol. 25 6
Páginas: 111-117
ISSN: 0870-399X
Outras Informações
ID Authenticus: P-002-C73
Abstract (EN): Mephedrone is a semisynthetic derivative of cathinone used as a drug of abuse. Similar to amphetamine, both in chemical structure and associated signs and symptoms, has gained popularity since 2007 and it is currently the sixth most abused drug in United Kingdom. It can be easily purchased by the internet or smart shops where it is advertised as a fertilizer for plants or bath salts, although such efficacy was never proved. This article aims to review the state-of-the-art literature of mephedrone, particularly its chemical structure, forms of presentation, pharmacokinetics, pharmacodynamics, acute intoxications, diagnosis and therapy of intoxications. Mephedrone is mainly sought for the following symptoms: euphoria, social disinhibition, empathy, and increased libido. However, its use is associated with several adverse effects on cardiovascular, gastrointestinal, neurological, psychiatric and genitourinary systems, among others. There are also reported cases of consumers who have developed tolerance and dependence after a regular abuse of mephedrone. Several deaths in the United Kingdom have been confirmed as being directly related to the consumption of mephedrone. Currently this drug is legally controlled in many countries, but little is known about its pharmacokinetics and pharmacodynamics. Most data comes only from users and health professional's reports and internet surveys. Recently, the Portuguese Law 13/2012, 26 of March, included mephedrone in the list of controlled substances, and therefore it is important to better understand this xenobiotic.
Idioma: Português
Tipo (Avaliação Docente): Científica
Nº de páginas: 7
Documentos
Não foi encontrado nenhum documento associado à publicação.
Publicações Relacionadas

Da mesma revista

Why should SARS-CoV-2 post-pandemic recovery funding be used to foster a physician-scientist program? (2020)
Outra Publicação em Revista Científica Nacional
Barbosa Breda, J; Leal, I; Sousa, DC; Soares, CA
Why Should SARS-CoV-2 Post-Pandemic Recovery Funding Be Used to Foster a Physician-Scientist Program? (2020)
Outra Publicação em Revista Científica Nacional
Barbosa Breda, J; Leal, I; Sousa, DC; Soares, CA
The 2019 novel Coronavirus (2019-NCoV): Novel virus, old challenges [O Novo Coronavírus (2019-nCoV): Novo Vírus, Desafios Antigos] (2020)
Outra Publicação em Revista Científica Nacional
Duarte R; Furtado, I; Sousa, L; Carvalho, C
The Role of Pharmacovigilance in the COVID-19 Pandemic (2021)
Outra Publicação em Revista Científica Nacional
Ferreira Da Silva, R; Ribeiro Vaz, I; Morato, M; Silva, AM; Polonia, J
The impact of the COVID-19 pandemic in the management of occupational injuries [O impacto da pandemia COVID-19 na prestação de cuidados de saúde em sinistralidade laboral] (2020)
Outra Publicação em Revista Científica Nacional
Relvas Silva, M; Monteiro, E; Santos Carvalho, M; Negrão, P; Bettencourt, P; Neves, N; Ribeiro Silva, M

Ver todas (578)

Recomendar Página Voltar ao Topo
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Termos e Condições  I Acessibilidade  I Índice A-Z
Página gerada em: 2025-09-04 às 18:09:39 | Política de Privacidade | Política de Proteção de Dados Pessoais | Denúncias